| 000 | 01458 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515210451.0 | ||
| 264 | 0 | _c20100519 | |
| 008 | 201005s 0 0 eng d | ||
| 022 | _a1539-2570 | ||
| 024 | 7 |
_a10.1097/BPO.0b013e3181d075ab _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOetgen, Matthew E | |
| 245 | 0 | 0 |
_aComplications associated with the use of bone morphogenetic protein in pediatric patients. _h[electronic resource] |
| 260 |
_bJournal of pediatric orthopedics _cMar 2010 |
||
| 300 |
_a192-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aBone Morphogenetic Protein 2 |
| 650 | 0 | 4 |
_aBone Morphogenetic Proteins _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDura Mater _xpathology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFibrosis |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aFracture Healing _xdrug effects |
| 650 | 0 | 4 |
_aFractures, Ununited _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadverse effects |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSpinal Fusion _xmethods |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xadverse effects |
| 700 | 1 | _aRichards, B Stephens | |
| 773 | 0 |
_tJournal of pediatric orthopedics _gvol. 30 _gno. 2 _gp. 192-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/BPO.0b013e3181d075ab _zAvailable from publisher's website |
| 999 |
_c19548324 _d19548324 |
||